Is There any Concordance Between of IHC with FISH in HER2-Positive Breast Cancer Patients?
Background: In developed or developing countries, the most common cancer in women is breast cancer with a pick in 40–50 years in Asia. Herein, we compared the association between IHC with FISH in HER2-positive breast cancer patients and affection of trastuzumab on disease free survival and overall s...
Main Authors: | Mehrdad Payandeh, Masoud Sadeghi, Edris Sadeghi, Alireza Janbakhsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2016-12-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/534 |
Similar Items
-
Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses
by: Jin Y, et al.
Published: (2023-05-01) -
Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer
by: Liang Huang, et al.
Published: (2020-02-01) -
Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients
by: Shuai Li, et al.
Published: (2021-07-01) -
Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
by: Albouzidi Abderrahmane, et al.
Published: (2011-09-01) -
Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review
by: Julie Lebert, et al.
Published: (2022-04-01)